Loading...
OTC Markets
Totals
Securities
12,304
Dollar Vol
$2.5B
Share Vol
3.8B
Trades
319,611

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

TLTFF
Theralase Technologies Inc.

Ordinary Shares

N/A

N/A

N/A

Market Cap calculated only for this class of securities.

36,994,505

Real-Time Level 2 Quote
Trade Data
News
Filings and Disclosure
Company Description
Theralase Technologies Inc. Company Logo
Theralase Technologies Inc. ("Theralase" or "Company") (TSXV: TLT) (OTCQB: TLTFF) is a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations to safely and effectively destroy various cancers. The Company in its Laser Division designs, manufactures and distributes patented and proprietary medical laser technology.
Videos
OTCQB Venture Market Logo
Joined OTCQB 10/2018
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.